HEART UK consensus statement on Lipoprotein(a): A call to action

Cegla, Jaimini; Dermot G. Neely, R.; France, Michael; A. Ferns, Gordon; D. Byrne, Christopher; Halcox, Julian; Datta, D.; Capps, Nigel; C. Shoulders, Carol; Qureshi, Nadeem; Rees, Alan; Main, Linda; Cramb, Robert; Viljoen, Adie; Payne, Jules; Soran, Handrean

doi:10.1016/j.atherosclerosis.2019.10.011

Public

HEART UK consensus statement on Lipoprotein(a): A call to action

Published in Atherosclerosis • Oct 14, 2019

Authors:

Jaimini Cegla

R. Dermot G. Neely

Michael France

Abstract

Lipoprotein(a), Lp(a), is a modified atherogenic low-density lipoprotein particle that contains apolipoprotein(a). Its levels are highly heritable and variable in the population. This consensus statement by HEART UK is based on the evidence that Lp(a) is an independent cardiovascular disease (CVD) r...

Subject

Lipoprotein(a)

Medicine

Internal medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!